MFD-18532-63048
2 vaccinations
1 coded response
12 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 303 / GA
- Registered
- 2021-04-02
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-02
Registered in v-safe
-
2021-04-02
Dose 1 — Pfizer-BioNTech
- 2021-04-02
-
2021-04-03
Survey response — days 1–6 daily, dose 1MedDRA: Dysgeusia — Feeling: GoodFree text: slight metallic tasteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-04
- 2021-04-05
- 2021-04-06
- 2021-04-08
- 2021-04-11
- 2021-04-18
-
2021-04-23
Dose 2 — Pfizer-BioNTech
- 2021-04-23
- 2021-04-29
- 2021-04-30
- 2021-05-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-02 | Pfizer-BioNTech | |
| 2 | 2021-04-23 | Pfizer-BioNTech |
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): slight metallic taste
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Dysgeusia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release